insights_auto
Why is GALT down 5.41%?
Dive Deeperchevron_right
GALT:NASDAQ
Galectin Therapeutics Inc. Common Stock
$2.97
arrow_downward
-5.41%(-0.17) 1D
Nov 13, 9:58:28 AM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for GALT...
Open
$3.16
High
$3.31
Low
$2.95
Mkt. cap
299.52M
Avg. vol.
204.32K
Volume
18.44K
52-wk high
$7.13
52-wk low
$2.03
EPS
-$0.43
Beta
0.53
Shares outstanding
100.85M
No. of employees
9
Open
$3.16
High
$3.31
Low
$2.95
Mkt. cap
299.52M
Avg. vol.
204.32K
Volume
18.44K
52-wk high
$7.13
52-wk low
$2.03
EPS
-$0.43
Beta
0.53
Shares outstanding
100.85M
No. of employees
9
News stories
From web sources and news partners
ChartMill
·
1 hour ago
S&P 500 Premarket Movers: Travelers, Palo Alto Networks Gain; Cisco, AMD Fall
Reuters
·
41 minutes ago
Goldman Sachs sees S&P 500 rising to 8,700 next year despite slower earnings growth
24/7 Wall St.
·
39 minutes ago
He Wants Anthropic in His S&P 500 401(k) as Soon as It Goes Public. One Index Rule Could Keep It Out for at Least 12 Months. Even Then, His Fund May Never Own It
FOREX.com
·
3 hours ago
S&P 500 forecast: SPX struggles for direction ahead of PPI data
About Galectin Therapeutics Inc. Common Stock
CEO-
Employees9
Founded2000
HeadquartersNorcross, Georgia, United States
SectorHealth Care
IndustryBiotechnology
Websitegalectintherapeutics.com